Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Human CD11c (gp 150/95, Integrin αX, CR4, p150, ITGAX) In Vivo GOLD; Clone 3.9; Isotype: Mouse IgG1
SDP

Supplier:  Leinco Technologies Inc C3691.0 MG

Encompass_Preferred

Specificity: Clone 3.9 recognizes the -chain (CD11c) of the CD11c/CD18 complex. It is specific for the I domain of CD11c. 3.9 binds the activated form of CD11c and partially blocks the binding of CD11c with ICAM-4. Antigen Distribution: CD11c is present on monocytes, granulocytes and NK cells. It is strongly expressed in hairy cell leukemia and in some acute myeloid leukemias. Background: CD11c is 150 kDa and forms an /ß heterodimeric glycoprotein which belongs to the ß2 integrin family. Applications: (FC, WB) When analyzing blood, the usage of EDTA as an anti-coagulant may be detrimental to staining due to its chelating properties. 3.9 stains true histiocytic lymphomas. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6071


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.